| 000 | 01722 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515233116.0 | ||
| 264 | 0 | _c20101227 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2010.06.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJalving, Mathilde | |
| 245 | 0 | 0 |
_aMetformin: taking away the candy for cancer? _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cSep 2010 |
||
| 300 |
_a2369-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdipokines _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle _xphysiology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aGonadal Steroid Hormones _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin Resistance _xphysiology |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor Binding Protein 1 _xphysiology |
| 650 | 0 | 4 |
_aMetformin _xtherapeutic use |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aGietema, Jourik A | |
| 700 | 1 | _aLefrandt, Joop D | |
| 700 | 1 | _ade Jong, Steven | |
| 700 | 1 | _aReyners, Anna K L | |
| 700 | 1 | _aGans, Rijk O B | |
| 700 | 1 | _ade Vries, Elisabeth G E | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 46 _gno. 13 _gp. 2369-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2010.06.012 _zAvailable from publisher's website |
| 999 |
_c19996837 _d19996837 |
||